Omnicell, Inc. (OMCL): Price and Financial Metrics


Omnicell, Inc. (OMCL): $154.77

-9.71 (-5.90%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

OMCL POWR Grades


  • Growth is the dimension where OMCL ranks best; there it ranks ahead of 97.95% of US stocks.
  • The strongest trend for OMCL is in Quality, which has been heading down over the past 157 days.
  • OMCL ranks lowest in Momentum; there it ranks in the 14th percentile.

OMCL Stock Summary

  • OMCL's current price/earnings ratio is 90.07, which is higher than 92.05% of US stocks with positive earnings.
  • The price/operating cash flow metric for OMNICELL Inc is higher than 81.57% of stocks in our set with a positive cash flow.
  • In terms of twelve month growth in earnings before interest and taxes, OMNICELL Inc is reporting a growth rate of 161.73%; that's higher than 86.75% of US stocks.
  • If you're looking for stocks that are quantitatively similar to OMNICELL Inc, a group of peers worth examining would be PRFT, SGH, TECH, ECOM, and AMG.
  • OMCL's SEC filings can be seen here. And to visit OMNICELL Inc's official web site, go to www.omnicell.com.

OMCL Valuation Summary

  • In comparison to the median Technology stock, OMCL's price/sales ratio is 30.19% higher, now standing at 6.9.
  • Over the past 243 months, OMCL's price/earnings ratio has gone up 131.6.
  • Over the past 243 months, OMCL's EV/EBIT ratio has gone up 105.1.

Below are key valuation metrics over time for OMCL.

Stock Date P/S P/B P/E EV/EBIT
OMCL 2021-09-01 6.9 6.5 114.9 85.8
OMCL 2021-08-31 6.8 6.4 113.0 84.4
OMCL 2021-08-30 6.9 6.4 113.3 84.6
OMCL 2021-08-27 7.0 6.6 115.5 86.3
OMCL 2021-08-26 6.8 6.4 112.5 84.0
OMCL 2021-08-25 6.9 6.4 113.6 84.8

OMCL Growth Metrics

    The 5 year price growth rate now stands at 116.77%.
  • Its 5 year cash and equivalents growth rate is now at 94.59%.
  • Its 3 year net cashflow from operations growth rate is now at 152.3%.
OMCL's revenue has moved up $379,990,000 over the prior 49 months.

The table below shows OMCL's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 1,070.186 248.625 80.245
2021-06-30 987.483 242.323 59.733
2021-03-31 914.365 218.054 35.01
2020-12-31 892.208 185.87 32.194
2020-09-30 891.298 144.242 37.912
2020-06-30 906.404 163.983 49.09

OMCL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • OMCL has a Quality Grade of C, ranking ahead of 58.08% of graded US stocks.
  • OMCL's asset turnover comes in at 0.534 -- ranking 55th of 83 Computers stocks.
  • STRM, PBI, and CERN are the stocks whose asset turnover ratios are most correlated with OMCL.

The table below shows OMCL's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.534 0.485 0.087
2021-03-31 0.550 0.466 0.054
2020-12-31 0.595 0.463 0.052
2020-09-30 0.658 0.464 0.064
2020-06-30 0.734 0.473 0.105
2020-03-31 0.752 0.486 0.148

OMCL Price Target

For more insight on analysts targets of OMCL, see our OMCL price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $167.50 Average Broker Recommendation 1.55 (Moderate Buy)

OMCL Stock Price Chart Interactive Chart >

Price chart for OMCL

OMCL Price/Volume Stats

Current price $154.77 52-week high $187.29
Prev. close $164.48 52-week low $116.07
Day low $154.62 Volume 472,909
Day high $163.60 Avg. volume 330,973
50-day MA $176.30 Dividend yield N/A
200-day MA $156.25 Market Cap 6.80B

Omnicell, Inc. (OMCL) Company Bio


Omnicell provides automation and business analytics software for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. The company was founded in 1992 and is based in Mountain View, California.


OMCL Latest News Stream


Event/Time News Detail
Loading, please wait...

OMCL Latest Social Stream


Loading social stream, please wait...

View Full OMCL Social Stream

Latest OMCL News From Around the Web

Below are the latest news stories about OMNICELL Inc that investors may wish to consider to help them evaluate OMCL as an investment opportunity.

Top Robotics Stocks for Q1 2022

The number of robotics and automation companies has increased dramatically in recent decades as corporations seek to produce goods and services more efficiently, often replacing more expensive human employees in the process. Examples of companies that offer robotics solutions and products include Cognex Corp. (CGNX), Cadence Design Systems Inc. (CDNS), and U.K.-based Blue Prism Group PLC (PRSM). Robot and automation stocks, as represented by the ROBO Global Robotics and Automation Index ETF (ROBO), have underperformed the broader market.

Yahoo | January 13, 2022

Ford Motor and IRobot have been highlighted as Zacks Bull and Bear of the Day

Ford Motor and IRobot have been highlighted as Zacks Bull and Bear of the Day

Yahoo | January 7, 2022

Omicron Hits Elective MedTechs, 3 Subsectors Likely to Thrive

Here we discuss three major subsectors of MedTech and three constituent stocks, OPCH, GMED and OMCL for which the change in the scenario has opened up enormous growth prospects.

Yahoo | January 6, 2022

Omnicell to Release Fourth-Quarter and Full-Year 2021 Financial Results on February 14, 2022

MOUNTAIN VIEW, Calif., January 05, 2022--Omnicell to Release Fourth-Quarter and Full-Year 2021 Financial Results on February 14, 2022

Yahoo | January 5, 2022

Omnicell (OMCL) to Expand EnlivenHealth Division With New Buyout

Omnicell's (OMCL) $82-million buyout of MarkeTouch Media is likely to expand its Advanced Services portfolio.

Yahoo | January 5, 2022

Read More 'OMCL' Stories Here

OMCL Price Returns

1-mo -11.62%
3-mo -6.21%
6-mo 1.76%
1-year N/A
3-year 128.92%
5-year 355.88%
YTD -14.23%
2021 50.34%
2020 46.87%
2019 33.44%
2018 26.27%
2017 43.07%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9837 seconds.